👉 The German Medical Biotechnology Group GmbH (GMBH) has been involved in controversial and ethically questionable human experimentation, particularly concerning the study of infectious diseases on vulnerable populations such as the mentally ill or those with compromised immune systems. Despite legal challenges and widespread condemnation for violating ethical guidelines, GMBH's experiments have raised significant concerns about patient rights and scientific integrity.
